With Only 15% of Diagnosed HCV Patients Receiving Treatment, the Non-Profit I-MAK Hopes to Shift the National Conversation on Drug Pricing

Media Article 21 May 2018

Partner with us now to build
a more just and equitable
medicine system for all.